Esophageal cancer tumorspheres involve cancer stem-like populations with elevated aldehyde dehydrogenase enzymatic activity

Zhang,Gong; Ma,Lei; Xie,You-Ke; Miao,Xiao-Bo; Jin,Chuan

doi:10.3892/mmr.2012.939

Esophageal cancer tumorspheres involve cancer stem-like populations with elevated aldehyde dehydrogenase enzymatic activity

Authors:
- Gong Zhang
- Lei Ma
- You-Ke Xie
- Xiao-Bo Miao
- Chuan Jin
View Affiliations

Affiliations: Cancer Research Institute of Southern Medical University, Guangzhou 510515, P.R. China, Internal Medical Department of Guangzhou Medical University Cancer Institute and Hospital, Guangzhou 510182, P.R. China
Published online on: June 8, 2012 https://doi.org/10.3892/mmr.2012.939
Pages: 519-524

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cancer stem cells (CSCs) form spheres in vitro in serum-free suspension culture. Sphere formation is particularly useful to enrich the potential CSC subpopulations as a functional approach. Few reports are currently available on tumorspheres in esophageal cancer (EC). The present study focused on evaluating the cancer stem-like properties and analyzing the difference between spheroid and adherent cells of the Eca109 human EC cell line. Immunofluorescence and immunoblotting analysis revealed that EC tumorspheres expressed the stem cell markers Nanog and Oct4 more highly, but showed a decreased expression of the differentiation marker CK5/6. The spheroids were chemoresistant to cisplatin compared to the adherent cells (32.5 vs. 135.8 µM in IC50). Side population cells increased in tumorspheres compared to adherent cells (0.7 vs. 5.6%). A marked upregulation of drug-resistant genes (ABCG2 and MDR1) was observed in sphere-forming cells. We compared the profiles of adherent and spheroid cells by microarrays and obtained one representative differentially expressed gene, aldehyde dehydrogenase (ALDH). We also verified that the cancer stem-like cells of EC contained a high ALDH enzymatic activity. ALDH-positive cells were enriched by 11- to 12-fold in spheroids, compared to adherent cells (2.5 vs. 28.6%). Immunofluorescence and immunoblotting analysis also revealed a higher expression of ALDH in EC tumorspheres. In conclusion, our study verified that sphere-forming culturing can be utilized to demonstrate the putative esophageal CSCs, and identified a potential esophageal CSC surface marker, ALDH.

View Figures

View References

1	Ekman S, Dreilich M, Lennartsson J, Wallner B, Brattström D, Sundbom M and Bergqvist M: Esophageal cancer: current and emerging therapy modalities. Expert Rev Anticancer Ther. 8:1433–1448. 2008. View Article : Google Scholar : PubMed/NCBI
2	Aminian A, Panahi N, Mirsharifi R, Karimian F, Meysamie A, Khorgami Z and Alibakhshi A: Predictors and outcome of cervical anastomotic leakage after esophageal cancer surgery. J Cancer Res Ther. 7:448–453. 2011. View Article : Google Scholar : PubMed/NCBI
3	Dalerba P and Clarke MF: Cancer stem cells and tumor metastasis: first steps into uncharted territory. Cell Stem Cell. 1:241–242. 2007. View Article : Google Scholar : PubMed/NCBI
4	Dalerba P, Cho RW and Clarke MF: Cancer stem cells models and concepts. Annu Rev Med. 58:267–284. 2007. View Article : Google Scholar : PubMed/NCBI
5	Mathieu J, Zhang Z, Zhou W, et al: HIF induces human embryonic stem cell markers in cancer cells. Cancer Res. 71:4640–4652. 2011. View Article : Google Scholar : PubMed/NCBI
6	Greve B, Kelsch R, Spaniol K, Eich HT and Götte M: Flow cytometry in cancer stem cell analysis and separation. Cytometry A. 81:284–293. 2012. View Article : Google Scholar : PubMed/NCBI
7	Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ and Wicha M: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17:1253–1270. 2003. View Article : Google Scholar : PubMed/NCBI
8	Bez A, Corsini E, Curti D, Biggiogera M, Colombo A, Nicosia RF, Pagano SF and Parati EA: Neurosphere and neurosphere-forming cells: morphological and ultrastructural characterization. Brain Res. 993:18–29. 2003. View Article : Google Scholar : PubMed/NCBI
9	Shi X, Gipp J and Bushman W: Anchorage-independent culture maintains prostate stem cells. Dev Biol. 312:396–406. 2007. View Article : Google Scholar : PubMed/NCBI
10	Zhang S, Balch C, Chan MW, et al: Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 68:4311–4320. 2008. View Article : Google Scholar : PubMed/NCBI
11	Fujii H, Honoki K, Tsujiuchi T, Kido A, Yoshitani K and Takakura Y: Sphereforming stem-like cell populations with drug resistance in human sarcoma cell lines. Int J Oncol. 34:1381–1386. 2009.PubMed/NCBI
12	Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C and De Maria R: Identification and expansion of human colon-cancer-initiating cells. Nature. 445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
13	Ponti D, Costa A, Zaffaroni N, et al: Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
14	Podolski-Renić A, Andelković T, Banković J, Tanić N, Ruždijić S and Pešić M: The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines. Biomed Pharmacother. 65:345–353. 2011.PubMed/NCBI
15	Ding XW, Wu JH and Jiang CP: ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy. Life Sci. 86:631–637. 2010. View Article : Google Scholar : PubMed/NCBI
16	Tabor MH, Clay MR, Owen JH, Bradford CR, Carey TE, Wolf GT and Prince ME: Head and neck cancer stem cells: the side population. Laryngoscope. 121:527–533. 2011. View Article : Google Scholar : PubMed/NCBI
17	Stagos D, Chen Y, Brocker C, et al: Aldehyde dehydrogenase 1B1: molecular cloning and characterization of a novel mitochondrial acetaldehyde-metabolizing enzyme. Drug Metab Dispos. 38:1679–1687. 2010. View Article : Google Scholar : PubMed/NCBI
18	Ma I and Allan AL: The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev. 7:292–306. 2011. View Article : Google Scholar : PubMed/NCBI
19	Kunisaki C, Makino H, Kimura J, et al: Therapeutic strategy for esophageal cancer based on solitary lymph node metastasis. Hepatogastroenterology. 58:1561–1565. 2011.PubMed/NCBI
20	Wu C and Alman BA: Side population cells in human cancers. Cancer Lett. 268:1–9. 2008. View Article : Google Scholar
21	Li H, Gao Q, Guo L and Lu SH: The PTEN/PI3K/Akt pathway regulates stem-like cells in primary esophageal carcinoma cells. Cancer Biol Ther. 11:950–958. 2011. View Article : Google Scholar : PubMed/NCBI
22	Tsunoda S, Okumura T, Ito T, et al: ABCG2 expression is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma. Oncology. 71:251–258. 2006. View Article : Google Scholar : PubMed/NCBI
23	Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W and Kunz-Schughart LA: Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol. 148:3–15. 2010. View Article : Google Scholar : PubMed/NCBI
24	Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J and Dirks P: Identification of a cancer stem cell in human brain tumors. Cancer Res. 63:5821–5828. 2003.PubMed/NCBI
25	Gibbs CP, Kukekov VG, Reith JD, et al: Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia. 7:967–976. 2005. View Article : Google Scholar : PubMed/NCBI
26	Fang D, Nguyen TK, Leishear K, et al: A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res. 65:9328–9337. 2005. View Article : Google Scholar : PubMed/NCBI
27	Gou S, Liu T, Wang C, Yin T, Li K, Yang M and Zhou J: Establishment of clonal colony-forming assay for propagation of pancreatic cancer cells with stem cell properties. Pancreas. 34:429–435. 2007. View Article : Google Scholar : PubMed/NCBI
28	Ma S, Chan KW, Lee TK, Tang KH, Wo JY, Zheng BJ and Guan XY: Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res. 6:1146–1153. 2008. View Article : Google Scholar : PubMed/NCBI
29	Wang Y, Zhe H, Gao P, Zhang N, Li G and Qin J: Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China. Dis Esophagus. Nov;2011.(E-pub ahead of print).